Teva Pharmaceutical Industries Ltd. ADR 1.42% $19.56B ...

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint, keeping the drugmaker on track to launch the first treatment for the relentless itching experienced by some ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

As on 30-06-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2278.60 as on 16 Dec, 2024, 03:31 PM IST. On previous day, the GSK Pharma Share Price ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

If you are looking for a gadget support center nearby to solve all your device problems, then we have you sorted with this best service center in Mumbai. Jio Service Center - Rpl House, Ballard, ...

LONDON — A blood cancer treatment from GSK helped patients live longer in a pivotal trial, a significant finding as the once-withdrawn drug mounts a comeback. In the study, a treatment ...

A software engineer died of a heart attack while playing cricket in Mumbai's Azad Maidan last week on Sunday.

GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.

The booking for the eight special trains will open from December 21, 2024 at all PRS Counters and on IRCTC website ...